Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
GeneDx GeneDx (US:WGS) Businesswire·2026-03-11 21:00

Core Insights - A landmark study indicates that GeneDx Exome and Genome Testing results in average cost savings of $80,000 per child, alongside overall improved health outcomes [1] Cost Savings - The average cost savings per child from GeneDx testing is reported to be $80,000 [1] Health Outcomes - The study highlights that GeneDx testing leads to overall improved health outcomes for children [1]

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing - Reportify